mBER-2: new AI protein design system targets in vivo drug delivery
AllThingsApx · x · 2026-09-23
Pierce Ogden announced mBER-2, an AI protein design system for exploring in vivo biology at scale. Focus: drug delivery — most receptors remain unexplored as delivery routes, and the team wants to identify usable ones and the molecules that make delivery possible. Backed by six years of measurement tech generating millions of in vivo measurements to validate candidate molecules.
Related event: Manifold Bio Releases mBER-2 for AI Protein Design and Drug Delivery(2 posts)→
More from Research
- MatBrain splits reasoning from tool use: two models screen 30,000 crystal candidates in 48 hours — bravo_abad · 2026-09-23
- Scale AI launches SWE-Bench Pro V2, a harder agentic coding benchmark — bigblueboo · 2026-09-23
- If AI Writes All the Papers, Peer Review Becomes Humanity's Remaining Role — sudoraohacker · 2026-09-23
- Yarin Gal: I Ignore Papers Where the Candidate Isn't First or Last Author — yaringal · 2026-09-23
- New paper: Transferring the Intelligence of VLMs to Robotic Control — _akhaliq · 2026-09-23
- NTU UMM study: generation training boosts understanding in native multimodal models, but naive sharing conflicts — jiqizhixin · 2026-09-23